<?xml version="1.0"?>
<presentation title="03 HJ Choi" width="1024.0000000" height="768.0000000" thmbWidth="78.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{7758A542-BD85-413F-8BF0-F1C3BD8E74E2}">
	<presenters>
		<presenter name="HJ Choi " title="Department of Internal Medicine SoonChunHyang University School of Medicine  Bucheon and Seoul, KOREA" email="" web="" phone="" photoAssetId="">
			<bio>Usefulness of EUS-guided sampling using core biopsy needle with onsite evaluation for diagnosis of metastatic liver mass</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets/>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<videoTracks>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11404952" width="240" height="180">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="2.8790000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11406044" width="240" height="180">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="15.2780000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11407635" width="240" height="180">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="22.1000000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11408524" width="240" height="180">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="10.5500000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11409694" width="240" height="180">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="15.9750000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11410833" width="240" height="180">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="14.4399996"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11411863" width="240" height="180">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="12.9560000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11412830" width="240" height="180">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="12.0699997"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11413469" width="240" height="180">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="4.6399999"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11414265" width="240" height="180">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="9.5660000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e4e20.spr0_11415388" width="240" height="180">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="15.4180000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e4e20.spr0_11416293" width="240" height="180">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="11.3770000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e4e20.spr0_11417182" width="240" height="180">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="8.9600000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e4e20.spr0_11418368" width="240" height="180">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="17.5499992"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11419663" width="240" height="180">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="18.2970000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11421207" width="240" height="180">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="22.4300000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11422611" width="240" height="180">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="19.6399994"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_354e2500.spr0_11423750" width="240" height="180">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="13.4200000"/>
			</videoTrack>
		</videoTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="true"/>
					<button type="presenterInfo" visible="true"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>false</showPresenterInfo>
				<showPresenterVideo>true</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>true</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="never"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="Usefulness of EUS-guided sampling using core biopsy needle with onsite evaluation for diagnosis of metastatic liver mass" titleNormalized="usefulness of eus-guided sampling using core biopsy needle with onsite evaluation for diagnosis of metastatic liver mass" src="slide1.swf" size="2337" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="2.8790001"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Usefulness of EUS-guided sampling using core biopsy needle with onsite evaluation for diagnosis of metastatic liver mass
HJ Choi, JH Moon, YN Lee, MH Choi, TH Lee, TH Lee, SW Cha,
YD Cho, SH Park

Department of Internal Medicine 
SoonChunHyang University School of Medicine
Bucheon and Seoul, KOREA</text>
		</slide>
		<slide index="1" title="BACKGROUND" titleNormalized="background" src="slide2.swf" size="2773" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.2789997"/>
			</animationSteps>
			<notes>Metastatic liver masses can be originated from various solid organ malignancies. And accurate diagnosis may be helpful for the guidance of adequate treatment.</notes>
			<notesNormalized>metastatic liver masses can be originated from various solid organ malignancies. and accurate diagnosis may be helpful for the guidance of adequate treatment.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Metastatic liver masses can be originated from various solid organ malignancies. And accurate diagnosis may be helpful for the guidance of adequate treatment.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Histopathological diagnosis for metastatic liver masses
A very common target of metastatic tumors
Colon &gt; pancreas &gt; breast 
Optimal for deciding treatment
From supportive care to partial hepatectomy
Metastatic tumors with unknown primary site
Identification of the site of origin may be helpful for the guidance of adequate treatment
BACKGROUND
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="2" title="BACKGROUND" titleNormalized="background" src="slide3.swf" size="337366" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="22.0990004"/>
			</animationSteps>
			<notes>EUS-guided sampling for solid liver masses is feasible, safe and reliable modality in previous published studies. However, sufficient tissue acquisition is demanded for the confirmation of specific tumor type.</notes>
			<notesNormalized>eus-guided sampling for solid liver masses is feasible, safe and reliable modality in previous published studies. however, sufficient tissue acquisition is demanded for the confirmation of specific tumor type.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;EUS-guided sampling for solid liver masses is feasible, safe and reliable modality in previous published studies. However, sufficient tissue acquisition is demanded for the confirmation of specific tumor type.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-guided sampling for metastatic solid liver mass
Feasible, safe and reliable modality 
Diagnostic assessment and tissue sampling at the same time
On-site evaluation for confirmation of malignant cells
Helpful for rapid decision of treatment modality
Demand of histologic evaluation by tissue acquisition
For confirmation of specific tumor type
BACKGROUND
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="3" title="BACKGROUND" titleNormalized="background" src="slide4.swf" size="119326" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="10.5490002"/>
			</animationSteps>
			<notes>As you know, ProCore needle has the reverse bevel side hole to acquire effectively core tissue during needle pass.</notes>
			<notesNormalized>as you know, procore needle has the reverse bevel side hole to acquire effectively core tissue during needle pass.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;As you know, ProCore needle has the reverse bevel side hole to acquire effectively core tissue during needle pass.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-guided fine needle biopsy (EUS-FNB)
Obtaining tissue core for histologic evaluation
EchoTip ProCore® needle
 (Wilson-Cook medical, Winston-Salem, NC)
Side hole at its tip for tissue acquisition during puncture
BACKGROUND
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="4" title="AIM" titleNormalized="aim" src="slide5.swf" size="2368" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.9789995"/>
			</animationSteps>
			<notes>The aim of this study is to evaluate the clinical usefulness of the EUS-guided fine needle biopsy with on-site evaluation for the diagnosis of metastatic solid liver masses.</notes>
			<notesNormalized>the aim of this study is to evaluate the clinical usefulness of the eus-guided fine needle biopsy with on-site evaluation for the diagnosis of metastatic solid liver masses.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The aim of this study is to evaluate the clinical usefulness of the EUS-guided fine needle biopsy with on-site evaluation for the diagnosis of metastatic solid liver masses.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>AIM
 To evaluate the clinical usefulness of EUS-guided fine needle biopsy with on-site evaluation for the diagnosis of metastatic solid liver masses
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="5" title="PATIENTS" titleNormalized="patients" src="slide6.swf" size="2979" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="14.4389996"/>
			</animationSteps>
			<notes>We included patients with metastatic solid liver masses that was confirmed by prior imaging studies and needed to make accurate diagnosis for guiding management decision.</notes>
			<notesNormalized>we included patients with metastatic solid liver masses that was confirmed by prior imaging studies and needed to make accurate diagnosis for guiding management decision.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;We included patients with metastatic solid liver masses that was confirmed by prior imaging studies and needed to make accurate diagnosis for guiding management decision.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Study setting
Study period: March 2012 – January 2014
Retrospective analysis of a prospectively maintained database 
Inclusion criteria
Metastatic solid liver masses confirmed by imaging study (CT, MRI or EUS)
Metastatic solid liver masses that were need to make accurate diagnosis for guiding management decision
Exclusion criteria
Inability to perform EUS-FNB: intervening blood vessels or altered GI anatomy
Coagulopathy: INR &gt; 1.8 or platelet count &lt; 50,000/µL
PATIENTS
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="6" title="PROCEDURES" titleNormalized="procedures" src="slide7.swf" size="2871" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.9590000"/>
			</animationSteps>
			<notes>EUS-FNB was performed with stylet, 15 to 20 movements with fanlike pattern, and 5 to 10 mL suction.</notes>
			<notesNormalized>eus-fnb was performed with stylet, 15 to 20 movements with fanlike pattern, and 5 to 10 ml suction.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;EUS-FNB was performed with stylet, 15 to 20 movements with fanlike pattern, and 5 to 10 mL suction.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Instruments
Linear array echoendoscope: GF-UCT240 (Olympus)
EUS-FNA biopsy needle
22G EchoTip ProCore (Cook Endoscopy)
EUS-guided FNB
Transgastric approach
Puncture with stylet
15‒20 back-and-forth needle movements with fanlike pattern in the lesion
5‒10 mL of suction during sampling
PROCEDURES
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="7" title="PROCEDURES" titleNormalized="procedures" src="slide8.swf" size="404678" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.0689997"/>
			</animationSteps>
			<notes>Acquired samples were divided into triple preparations, on-site, cytologic and histologic analysis.</notes>
			<notesNormalized>acquired samples were divided into triple preparations, on-site, cytologic and histologic analysis.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Acquired samples were divided into triple preparations, on-site, cytologic and histologic analysis.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Triple sample preparation for one pass specimen
PROCEDURES
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL 
On-site analysis
Diff-Quick (Giemsa stain)
Cytologic analysis
Papanicolaou stain
Histologic analysis
H &amp; E stain with IHC*
*IHC, immunohistochemical stain</text>
		</slide>
		<slide index="8" title="ASSESSMENT" titleNormalized="assessment" src="slide9.swf" size="2884" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="4.6389999"/>
			</animationSteps>
			<notes>Definitions of assessments were like this.</notes>
			<notesNormalized>definitions of assessments were like this.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Definitions of assessments were like this.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Classification of results
On-site findings for malignancy
Positive / Atypia / Negative / Nondiagnostic
Cytologic and histologic findings for malignancy
Positive / Suspicious / Atypia / Negative / Nondiagnostic 
Reference standards for malignancy
Histopathological findings
Clinical data including imaging studies following of greater than 6 months
ASSESSMENT
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="9" title="CASE, Pancreatic Cancer with Liver Metastasis (54/F)" titleNormalized="case, pancreatic cancer with liver metastasis (54/f)" src="slide10.swf" size="399699" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="9.5689997"/>
			</animationSteps>
			<notes>993279 김은희

A.	CT showed a mass on left lobe of liver. 

Let me show a case. CT scan showed a mass on the pancreas and the liver left lobe.</notes>
			<notesNormalized>993279 김은희

a.	ct showed a mass on left lobe of liver. 

let me show a case. ct scan showed a mass on the pancreas and the liver left lobe.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;993279 김은희&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;A.	&lt;i&gt;CT showed a mass on left lobe of liver. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Let me show a case. CT scan showed a mass on the pancreas and the liver left lobe.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CASE, Pancreatic Cancer with Liver Metastasis (54/F)</text>
		</slide>
		<slide index="10" title="CASE, Pancreatic Cancer with Liver Metastasis (54/F)" titleNormalized="case, pancreatic cancer with liver metastasis (54/f)" src="slide11.swf" size="191290" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video0" videoClipId="ispring.resources_35334d50.spr0_11388275" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_35334d50.spr2_11388275" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<pauseVideo frameIndex="0" videoId="video0"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.4190001"/>
			</animationSteps>
			<notes>993279 김은희

EUS showed hypoechoic solid mass  in left lobe of liver  and EUS-FNB was done by 22G needle.

After confirming of intervening vessels, tissue sampling was performed with 22G needle.</notes>
			<notesNormalized>993279 김은희

eus showed hypoechoic solid mass in left lobe of liver and eus-fnb was done by 22g needle.

after confirming of intervening vessels, tissue sampling was performed with 22g needle.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;993279 김은희&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt;EUS showed hypoechoic solid mass  in left lobe of liver  and EUS-FNB was done by 22G needle.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After confirming of intervening vessels, tissue sampling was performed with 22G needle.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CASE, Pancreatic Cancer with Liver Metastasis (54/F)</text>
		</slide>
		<slide index="11" title="CASE, Pancreatic Cancer with Liver Metastasis (54/F)" titleNormalized="case, pancreatic cancer with liver metastasis (54/f)" src="slide12.swf" size="1687727" advanceOnTime="1" framesCount="127" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="126" playTime="5.2500000" pauseTime="6.1300001"/>
			</animationSteps>
			<notes>993279 김은희

Positivity for malignancy was confirmed by  on-site analysis (Diff-Quick stain, X400)
Cytological analysis revealed poorly differenciated adenocarcinoma (PAP, X400)

On-site evaluation revealed malignant cells. And cytologic result was cosistent with metastatic carcinoma.</notes>
			<notesNormalized>993279 김은희

positivity for malignancy was confirmed by on-site analysis (diff-quick stain, x400)
cytological analysis revealed poorly differenciated adenocarcinoma (pap, x400)

on-site evaluation revealed malignant cells. and cytologic result was cosistent with metastatic carcinoma.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;993279 김은희&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt;Positivity for malignancy was confirmed by  on-site analysis (Diff-Quick stain, X400)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt;Cytological analysis revealed poorly differenciated adenocarcinoma (PAP, X400)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;On-site evaluation revealed malignant cells. And cytologic result was cosistent with metastatic carcinoma.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CASE, Pancreatic Cancer with Liver Metastasis (54/F)
On-site, Diff-Quick Stain
Cytologic Evaluation
Cytology, PAP Stain</text>
		</slide>
		<slide index="12" title="CASE, Pancreatic Cancer with Liver Metastasis (54/F)" titleNormalized="case, pancreatic cancer with liver metastasis (54/f)" src="slide13.swf" size="2203275" advanceOnTime="1" framesCount="103" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="102" playTime="4.2500000" pauseTime="4.7100000"/>
			</animationSteps>
			<notes>993279 김은희

Small cell neuroendocrine carcinoma was diagnosed by histological analysis (H&amp;E, X100, X400)

Histologic result was also consistent with poorly differentiated metastatic carcinoma.</notes>
			<notesNormalized>993279 김은희

small cell neuroendocrine carcinoma was diagnosed by histological analysis (h&amp;e, x100, x400)

histologic result was also consistent with poorly differentiated metastatic carcinoma.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;993279 김은희&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt;Small cell neuroendocrine carcinoma was diagnosed by histological analysis (H&amp;amp;E, X100, X400)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Histologic result was also consistent with poorly differentiated metastatic carcinoma.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CASE, Pancreatic Cancer with Liver Metastasis (54/F)
Histologic Evaluation, H&amp;E Stain
x100
x400</text>
		</slide>
		<slide index="13" title="CASE, Pancreatic Cancer with Liver Metastasis (54/F)" titleNormalized="case, pancreatic cancer with liver metastasis (54/f)" src="slide14.swf" size="1970051" advanceOnTime="1" framesCount="247" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="246" playTime="10.2500000" pauseTime="7.2999992"/>
			</animationSteps>
			<notes>993279 김은희

Immunohistochemical stainig shows positive for CD 56 and synaptophysin and negative for Chromogranin-A. The Ki-67 index was more than 20%.

 Note: 1. CD56과 Synaptophysin 이 양성이라 neuroendocrine carcinoma 가 먼저 의심되나, osteoclast-like giaNt cell 이 많이 나오고 neuroendocrine carcinoma 의 핵의 특징적인 소견이 잘 관찰되지 않아 undifferentiated carcinoma with osteoclasit-like giant cells 의 가능성도 배제할 수 없습니다. 

After immunohistochemical analysis, final diagnosis was metastatic undifferentiated carcinoma with osteoclast-like giant cells.</notes>
			<notesNormalized>993279 김은희

immunohistochemical stainig shows positive for cd 56 and synaptophysin and negative for chromogranin-a. the ki-67 index was more than 20%.

 note: 1. cd56과 synaptophysin 이 양성이라 neuroendocrine carcinoma 가 먼저 의심되나, osteoclast-like giant cell 이 많이 나오고 neuroendocrine carcinoma 의 핵의 특징적인 소견이 잘 관찰되지 않아 undifferentiated carcinoma with osteoclasit-like giant cells 의 가능성도 배제할 수 없습니다. 

after immunohistochemical analysis, final diagnosis was metastatic undifferentiated carcinoma with osteoclast-like giant cells.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;993279 김은희&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt;Immunohistochemical stainig shows positive for CD 56 and synaptophysin and negative for Chromogranin-A. The Ki-67 index was more than 20%.&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;&lt;i&gt; Note: 1. CD56과 Synaptophysin 이 양성이라 neuroendocrine carcinoma 가 먼저 의심되나, osteoclast-like giaNt cell 이 많이 나오고 neuroendocrine carcinoma 의 핵의 특징적인 소견이 잘 관찰되지 않아 undifferentiated carcinoma with osteoclasit-like giant cells 의 가능성도 배제할 수 없습니다. &lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;After immunohistochemical analysis, final diagnosis was metastatic undifferentiated carcinoma with osteoclast-like giant cells.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CD56
CASE, Pancreatic Cancer with Liver Metastasis (54/F)
Histologic Evaluation, Immunohistochemical Stains
Synaptophysin
Chromogranin-A
Ki-67
 Metastatic undifferentiated carcinoma
with osteoclast-like giant cells</text>
		</slide>
		<slide index="14" title="RESULTS–1. Baseline Characteristics" titleNormalized="results–1. baseline characteristics" src="slide15.swf" size="3519" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.2989992"/>
			</animationSteps>
			<notes>Let me show study results. Total 25 patients undergone EUS-FNB for metastatic solid liver masses. Almost masses were located at left lobe. Most common diagnosis was pancreatic cancer.</notes>
			<notesNormalized>let me show study results. total 25 patients undergone eus-fnb for metastatic solid liver masses. almost masses were located at left lobe. most common diagnosis was pancreatic cancer.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Let me show study results. Total 25 patients undergone EUS-FNB for metastatic solid liver masses. Almost masses were located at left lobe. Most common diagnosis was pancreatic cancer.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RESULTS–1. Baseline Characteristics
Total number of patients	25
Age, mean±SD (range), years	64.8±15.0 (25‒87)
Male / Female, n	9 / 12
Location of tumor, n
	Left lobe / Right lobe	24 / 1
Size of tumor, mm, n (%)
	Median (range)	31 (14‒70)
	&lt; 20		 8 (32.0)
	20‒30	 8 (32.0)
	&gt; 30		 9 (36.0)
Final diagnosis, n (%)
	Pancreatic cancer	11 (44.0)
	Metastatic neuroendocrine tumor	 5 (20.0)
	Colon cancer	 3 (12.0)
	Stomach cancer	 2 ( 8.0)
	Gallbladder cancer	 2 ( 8.0)
	Ampulla of Vater cancer	 2 ( 8.0)
*SD, standard deviation
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="15" title="RESULTS–2. Technical Outcomes of EUS-FNB (n=34)" titleNormalized="results–2. technical outcomes of eus-fnb (n=34)" src="slide16.swf" size="3034" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="22.4290003"/>
			</animationSteps>
			<notes>The median number of needle passes for diagnosis was 1 with interquartile range of 1 to 2. Acquired samples were adequate for cytohistologic evaluation 100%, 96%, 92% and 84% respectively.</notes>
			<notesNormalized>the median number of needle passes for diagnosis was 1 with interquartile range of 1 to 2. acquired samples were adequate for cytohistologic evaluation 100%, 96%, 92% and 84% respectively.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The median number of needle passes for diagnosis was 1 with interquartile range of 1 to 2. Acquired samples were adequate for cytohistologic evaluation 100%, 96%, 92% and 84% respectively.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RESULTS–2. Technical Outcomes of EUS-FNB (n=34)
Number of needle passes for diagnosis
	Median (range)	1.0 (1‒4)
	Interquartile range	1.0‒2.0
Technical success, n (%)	25 (100)
Adequate specimen, n (%)
	On-site cytology	25 (100)
	Cytology with PAP stain	24 ( 96)
	Histology with H&amp;E stain	23 ( 92)
	Histology with IHC stain	21 ( 84)
Complications, n	 0 ( 0)
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="16" title="RESULTS–3. Diagnostic Yield of EUS-FNB of Metastatic Solid Liver Mass for Malignancy (n=25)" titleNormalized="results–3. diagnostic yield of eus-fnb of metastatic solid liver mass for malignancy (n=25)" src="slide17.swf" size="3062" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.6389994"/>
			</animationSteps>
			<notes>Diagnostic yields for malignancy were 100% in on-site cytology, 92% in cytology and 84% in histology. Diagnostic accuracy for the specific tumor type was 80%.</notes>
			<notesNormalized>diagnostic yields for malignancy were 100% in on-site cytology, 92% in cytology and 84% in histology. diagnostic accuracy for the specific tumor type was 80%.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Diagnostic yields for malignancy were 100% in on-site cytology, 92% in cytology and 84% in histology. Diagnostic accuracy for the specific tumor type was 80%.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RESULTS–3. Diagnostic Yield of EUS-FNB of Metastatic Solid Liver Mass for Malignancy (n=25)
Positive for malignancy, n (%)
	On-site cytology	 25 (100)
	Cytology with PAP stain	 23 ( 92)
	Histology using H&amp;E stain	 21 ( 84)
Overall diagnostic accuracy	100
 for malignancy (%)
Diagnostic accuracy	 80 (64.3‒95.7)
 for specific tumor type, % (95% CI)
*CI, confidential incidence
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
		<slide index="17" title="CONCLUSION" titleNormalized="conclusion" src="slide18.swf" size="2377" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="13.4190001"/>
			</animationSteps>
			<notes>In conclusion, EUS-guided sampling for metastatic solid liver masses may be helpful in the management of patients who need to get a accurate histopathological diagnosis. Thank you for your attention.</notes>
			<notesNormalized>in conclusion, eus-guided sampling for metastatic solid liver masses may be helpful in the management of patients who need to get a accurate histopathological diagnosis. thank you for your attention.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In conclusion, EUS-guided sampling for metastatic solid liver masses may be helpful in the management of patients who need to get a accurate histopathological diagnosis. Thank you for your attention.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CONCLUSION
 EUS-guided sampling for metastatic solid liver masses may be helpful in the management of patients who need to get a accurate histopathological diagnosis.
DIGESTIVE DISEASE CENTER SOON CHUN HYANG UNIVERSITY HOSPITAL</text>
		</slide>
	</slides>
</presentation>
